- Recent Funding
- Investors
- ArrowMark Partners
ArrowMark Partners portfolio
ArrowMark Partners has 6 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Skyryse's $300M Series B+ round in February 2026, alongside Fidelity Management & Research Company, Qatar Investment Authority, BAM Elevate and 7 others. By category, its portfolio leans toward Health and bio (6) and Legal and compliance (1). It has co-invested with Woodline Partners, Durable Capital Partners and Qatar Investment Authority, most often Woodline Partners (2 rounds).
What ArrowMark Partners invests in
- Health and bio · 6 · 100%
- Legal and compliance · 1 · 17%
- Robotics and hardware · 1 · 17%
ArrowMark Partners recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $300M | Fidelity Management & Research Company (lead), Qatar Investment Authority, BAM Elevate +7 | ||
| Series B+ · $65M | Taiho Ventures, Jacket River, HBM Healthcare Investments (lead) +6 | ||
| Series B+ · $75M | Gilde Healthcare, Morningside, Octopus Ventures +2 | ||
| Series B+ · $88.5M | DCVC Bio, Droia Ventures, Deep Track Capital +6 |
How ArrowMark Partners invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 4 100% | $528.5M |
ArrowMark Partners portfolio companies
SSkyryse$300MSeries B+ · Feb 2026
DDren Bio$65MSeries B+ · Jun 2022BBig Health$75MSeries B+ · Jan 2022
FFrontier Medicines$88.5MSeries B+ · Jul 2021
FFormation Biobacker
AArbor Biotechnologiesbacker
| Company | Round with ArrowMark Partners | Total raised | Latest raise |
|---|---|---|---|
Legal and compliance |
Series B+ · $300M | $513M | Feb 3, 2026 Series B+ |
Health and bio |
Series B+ · $65M | $415M | Oct 29, 2026 round |
Health and bio |
Series B+ · $75M | $129.3M | Jan 19, 2022 Series B+ |
Health and bio |
Series B+ · $88.5M | $235.5M | Aug 28, 2025 Series B+ |
Health and bio |
backer | $372M | Jun 26, 2024 Series B+ |
Health and bio |
backer | $289M | Mar 18, 2025 Series B+ |
Most frequent co-investors
WWoodline Partners2 shared rounds · last Feb 3, 2026
DDurable Capital Partners1 shared round · last Feb 3, 2026
QQatar Investment Authority1 shared round · last Feb 3, 2026
AAtreides Management1 shared round · last Feb 3, 2026
- FFidelity Management & Research Company1 shared round · last Feb 3, 2026
BBaron Capital1 shared round · last Feb 3, 2026
PPositive Sum1 shared round · last Feb 3, 2026
BBAM Elevate1 shared round · last Feb 3, 2026
AAutopilot Ventures1 shared round · last Feb 3, 2026
RRokos Capital Management1 shared round · last Feb 3, 2026
BBiotechnology Value Fund1 shared round · last Jun 14, 2022
TTaiho Ventures1 shared round · last Jun 14, 2022
Similar investors
AAdage Capital Management6 companies · 4 deals in 12 mo
HHealthier Capital6 companies · 4 deals in 12 mo
SSymBiosis6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moAAbingworth6 companies · 3 deals in 12 mo
HHBM Healthcare Investments6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 4 rounds on Recent Funding that name ArrowMark Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists ArrowMark Partners, which is a subset of its real portfolio. API: /api/v1/investors/arrowmark-partners (get a free API key). More: the most active VC firms and new venture capital funds.